Our Letter to the Editor is published in the ESC Heart Failure:
The adult congenital heart disease population continues to grow in the United States and worldwide, emphasizing a need for greater research on this group. In adult congenital heart disease patients, sudden cardiac death is the most frequent cause of death, and S-ICD can be an important life-saving treatment option. Further studies and technological developments are needed to improve S-ICD technology and reduce the number of ineligible S-ICD adult congenital heart disease patients. To summarize research evidence, future systematic reviews and meta-analyses will likely be needed. An accurate, detailed, and reproducible methods and results have the greatest impact on what new studies can expand on in the adult congenital heart disease population.